Covered recipient · General Payments record
KEVIN ROLANDO WILLIAMS
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2025
$10,557.20
- Reported across 114 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $7,713.00 | 2 |
| Food and Beverage | $587.67 | 13 |
| Education | $45.00 | 1 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $7,713.00 | 2 |
| Amgen Inc. | $153.36 | 4 |
| ABBVIE INC. | $150.01 | 4 |
| IDORSIA PHARMACEUTICALS US INC | $134.91 | 2 |
| Acerta Pharma LLC | $109.06 | 1 |
| Lilly USA, LLC | $45.00 | 1 |
| Exact Sciences Corporation | $21.84 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18.49 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $3.32 | 03/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204128352 | CMS |
| ABBVIE INC. | $119.15 | 04/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204128358 | CMS |
| ABBVIE INC. | $16.81 | 10/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204128363 | CMS |
| ABBVIE INC. | $10.73 | 12/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204128369 | CMS |
| Amgen Inc. | $1.79 | 08/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228766268 | CMS |
| Amgen Inc. | $26.75 | 09/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228766272 | CMS |
| Amgen Inc. | $123.12 | 11/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228766261 | CMS |
| Amgen Inc. | $1.70 | 12/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228766275 | CMS |
| AstraZeneca Pharmaceuticals LP | $109.06 | 08/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206489313 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18.49 | 08/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1222814008 | CMS |
| Exact Sciences Corporation | $21.84 | 11/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235240857 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $51.47 | 11/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1243415859 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $83.44 | 11/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1243416184 | CMS |
| Lilly USA, LLC | $45.00 | 01/14/2025 | Education | Undisputed | 06/30/2026 | 1187137201 | CMS |
| Teva Pharmaceuticals USA, Inc. | $7,223.00 | 04/29/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1247437392 | CMS |
| Teva Pharmaceuticals USA, Inc. | $490.00 | 08/29/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1247437434 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2021, 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.